Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with NHL undergoing chemotherapy: Initial results from an integrated analysis - The neulasta versus current neutropenia management practice (Neucup) project.
Publication
, Conference
Pettengell, R; Skacel, T; Aapro, M; Duehrsen, U; Easton, V; Lyman, G
Published in: BLOOD
2006
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
2006
Volume
108
Issue
11
Start / End Page
340A / 341A
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Pettengell, R., Skacel, T., Aapro, M., Duehrsen, U., Easton, V., & Lyman, G. (2006). Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with NHL undergoing chemotherapy: Initial results from an integrated analysis - The neulasta versus current neutropenia management practice (Neucup) project. In BLOOD (Vol. 108, pp. 340A-341A).
Pettengell, Ruth, Tomas Skacel, Matti Aapro, Ulrich Duehrsen, Valerie Easton, and Gary Lyman. “Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with NHL undergoing chemotherapy: Initial results from an integrated analysis - The neulasta versus current neutropenia management practice (Neucup) project.” In BLOOD, 108:340A-341A, 2006.
Pettengell R, Skacel T, Aapro M, Duehrsen U, Easton V, Lyman G. Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with NHL undergoing chemotherapy: Initial results from an integrated analysis - The neulasta versus current neutropenia management practice (Neucup) project. In: BLOOD. 2006. p. 340A-341A.
Pettengell, Ruth, et al. “Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with NHL undergoing chemotherapy: Initial results from an integrated analysis - The neulasta versus current neutropenia management practice (Neucup) project.” BLOOD, vol. 108, no. 11, 2006, pp. 340A-341A.
Pettengell R, Skacel T, Aapro M, Duehrsen U, Easton V, Lyman G. Pegfilgrastim provides effective primary prophylaxis against febrile neutropenia in patients with NHL undergoing chemotherapy: Initial results from an integrated analysis - The neulasta versus current neutropenia management practice (Neucup) project. BLOOD. 2006. p. 340A-341A.
Published In
BLOOD
ISSN
0006-4971
Publication Date
2006
Volume
108
Issue
11
Start / End Page
340A / 341A
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology